Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Brain Tumor (Pediatric) Clinical Trials

A listing of Brain Tumor (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (13) clinical trials

Patients are needed to participate in a clinical research study of Oligodendroglioma to evaluate Palbociclib

This multicenter, open-label, phase II trial aims to assess the safety and efficacy of palbociclib in adult patients with Oligodendroglioma or recurrent oligoastrocytoma anaplastic with the activity of the protein RB preserved.


A clinical trial sponsored by National Cancer Institute (NCI) for a research study for the treatment of Optic Nerve Glioma, von Recklinghausen's Disease, Plexiform Neurofibroma, Nerve Sheath Tumors, neurofibroma

BACKGROUND Neurofibromatosis Type 1 (NF1) is an autosomal dominant, progressive genetic disorder characterized by diverse clinical manifestations. Patients with NF1 have an increased risk of developing tumors of the central and peripheral nervous system including plexiform neurofibromas (PN), dermal neurofibromas, optic pathway tumors, brain tumors, malignant peripheral nerve sheath tumors ...

Phase N/A

Patients are needed to participate in a clinical research study evaluating Carboplatin, Vincristine, Bevacizumab, Irinotecan, Mebendazole, Temozolomide for the treatment of Diffuse Intrinsic Pontine Glioma, Pleomorphic Xanthoastrocytoma, Astrocytoma, Optic Nerve Glioma, gliosarcoma, Glioblastoma Multiforme, Brainstem Glioma, Low Grade Glioma, Pilomyxoid Astrocytoma, DIPG

This is a phase I/II study of mebendazole in combination with standard of care agents for pediatric patients with gliomas. Patients with low-grade gliomas will receive a regimen of mebendazole in combination with vincristine, carboplatin, and temozolomide. Patients with high-grade gliomas and diffuse intrinsic pontine gliomas will receive a regimen ...


A Phase 1 clinical study for patients with Glioma, Astrocytoma, Oligodendroglioma, gliosarcoma, Glioblastoma Multiforme, Anaplastic Oligoastrocytoma

PVSRIPO will be delivered intratumorally by CED using an intracerebral catheter placed within the enhancing portion of the tumor. The population group are patients with recurrent WHO grade III or IV malignant glioma who are aged 12 through 18 years old. After a single dose of PVSRIPO, subjects will return ...


A clinical trial seeking patients for a research study for the treatment of Diffuse Intrinsic Pontine Glioma, Pediatric Brain Tumor

Eligible patients will be stratified to one of two arms, according to clinical indication for tumor resection. Pediatric patients who are scheduled for craniotomy and tumor resection will receive one dose of veledimex before the resection procedure. Ad-RTS-hIL-12 will be administered by free-hand injection. Patients will continue on oral veledimex ...


A clinical research study of rQNestin34.5v.2, Cyclophosphamide for the treatment of Astrocytoma, Oligodendroglioma, Pylocytic/Pylomyxoid Astrocytoma, Malignant Glioma of Brain, Ganglioglioma, Ependymoma, Anaplastic Oligodendroglioma of Brain (Diagnosis)

This research study is a Phase I clinical trial, which tests the safety of an investigational drug and also tries to define the appropriate dose of the investigational drug as a possible treatment for this diagnosis. "Investigational" means that the intervention is being studied. The FDA (the U.S. Food and ...


Patients are needed to participate in a clinical research study to evaluate Central Nervous System Neoplasms, Medulloblastoma

This is a Phase 2 multi-center, open-label, parallel-group study that will assess the efficacy, safety and tolerability of pomalidomide in children and young adults aged 1 to < 21 years with recurrent or progressive primary brain tumors after at least one prior standard therapy. The study will consist of 4 ...


Patients are needed to participate in a clinical research study evaluating Lapatinib Ditosylate

PRIMARY OBJECTIVES: I. To achieve an intratumoral lapatinib (lapatinib ditosylate) concentration of at least 1.5 uM in at least 70% of patients 3 hours after the last dose of pulsatile lapatinib. (Group A) II. To determine the pharmacodynamic (PD) effect of pulsatile lapatinib (at pulsatile maximum tolerated dose [MTD]) on ...

Phase N/A

Patients are needed to participate in a clinical research study evaluating Adavosertib

PRIMARY OBJECTIVES: I. To estimate the maximum tolerated dose (MTD) or recommended phase 2 dose and schedule of the WEE1 inhibitor AZD1775 (Wee1 inhibitor AZD1775 [MK-1775]) administered concurrently with radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). II. To define and describe the toxicities of WEE1 ...


Patients are needed to participate in a clinical research study of Central Nervous System Embryonal Tumors, Medulloblastoma to evaluate Tandem 3 Cycle Intensive Chemotherapy, Single Cycle Intensive Chemotherapy, Induction

Due to the inferior response and event-free survival data of Regimens D and D2 on "Head Start III" for all children with supratentorial embryonal tumors, in comparison with the published data from "Head Start II" with Regimen A2 for metastatic patients, all such patients will receive the "Head Start II" ...